Veritas Pharma Announces Debt Settlement

Vancouver, British Columbia–(Newsfile Corp. – July 28, 2020) – Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP) (“Veritas” or the “Company“) wishes to announces that it has entered into debt settlement agreements...

Veritas Pharma Announces Corrections to Financial Disclosures

VANCOUVER, British Columbia, May 21st, 2020 – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) wishes to announce that as a result of a review of its continuous disclosures record by the British Columbia Securities...

Veritas Pharma Announces Granting of Stock Options

VANCOUVER, British Columbia, April 27th, 2020 – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) wishes to announce that it has issued 1,215,789 options to directors and officers of the Company under the stock option...

The Veritas Newsletter

Enter your email to receive news alerts and updates from Veritas Pharma.

You have Successfully Subscribed!